Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
Multidrug-resistant (MDR) Gram-negative pathogens remain an unmet public health threat. In recent times, increased rates of resistance have been reported not only to commonly used antibiotics, but also to the last-resort antibiotics, such as polymyxins. More worryingly, despite the current trends in...
Main Authors: | Augustine Koh Jing Jie, Maytham Hussein, Gauri G. Rao, Jian Li, Tony Velkov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/11/12/1420 |
Similar Items
-
Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens
by: Thien B. Tran, et al.
Published: (2018-04-01) -
In vitro polymyxin activity against clinical multidrug-resistant fungi
by: Hanane Yousfi, et al.
Published: (2019-04-01) -
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae
by: Maytham Hussein, et al.
Published: (2022-01-01) -
Coarse-grained simulations uncover Gram-negative bacterial defense against polymyxins by the outer membrane
by: Xukai Jiang, et al.
Published: (2021-01-01) -
Untargeted metabolomics to evaluate polymyxin B toxicodynamics following direct intracerebroventricular administration into the rat brain
by: Maytham Hussein, et al.
Published: (2022-01-01)